Relmada Therapeutics Presents Development Program of REL1017 for Treatment of Depression at the 2019 American Society of Clinical Psychopharmacology Meeting - Yahoo Finance

Submitted by Anonymous (not verified) on Fri, 05/31/2019 - 12:00

Relmada Therapeutics Presents Development Program of REL1017 for Treatment of Depression at the 2019 American Society of Clinical Psychopharmacology Meeting  Yahoo FinanceFindings related to clinical safety and pharmacodynamic response together with evidence of activity in behavioral model of depression outlined in poster ...